• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CPI - DEL CARIBE ENDOTAK RELIANCE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CPI - DEL CARIBE ENDOTAK RELIANCE Back to Search Results
Model Number 0292
Device Problems Failure to Capture (1081); Device Contamination With Biological Material (2908); Device Dislodged or Dislocated (2923)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/21/2018
Event Type  Injury  
Manufacturer Narrative
This lead has been returned for analysis.This report will be updated upon completion of analysis.
 
Event Description
Boston scientific received information that this right ventricular (rv) lead dislodged one day post implant.The lead was revised at that time.Then the lead dislodged again and exhibited loss of capture.A surgical revision was performed and the lead was explanted and replaced to provide the patient with a longer lead.It was noted the physician was concerned about tissue in the helix.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the lead was performed.Visual inspection noted a cut in the insulation 14 centimeters (cm) from the terminal pin.The helix was extended with dried bodily fluid and tissue noted around the helix mechanism.Testing was completed to assess lead electrical performance and inner insulation integrity.Measurements throughout these tests were within normal limits.Laboratory testing was unable to reproduce the reported clinical observations and detailed analysis did not reveal any abnormalities.Laboratory analysis did not identify any lead characteristics that would have caused or contributed to the lead dislodgement.The cut in the lead insulation was noted to have occurred during explant.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE
Manufacturer (Section D)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer Contact
tim degroot
4100 hamline ave. n
st. paul, MN 
6515826168
MDR Report Key7408994
MDR Text Key104757719
Report Number2124215-2018-05920
Device Sequence Number1
Product Code NVY
UDI-Device Identifier00802526531248
UDI-Public00802526531248
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/09/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date12/09/2019
Device Model Number0292
Other Device ID NumberRELIANCE 4-SITE
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/28/2018
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received04/11/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/09/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
0292; D150
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age81 YR
-
-